The article discusses the increasing use of genomic markers to enhance traditional histopathology approaches for classification of cancer samples. Topics discussed include molecular classification of adult diffuse glioblastoma, identification of the common molecular sub-types of lower-grade glioma and classification of adult diffuse glioma.